Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Trial for Early Lesions Caused by M. Ulcerans - Comparison Between 8 Weeks Streptomycin and Rifampicin (SR), or 4 Weeks SR Followed by 4 Weeks R Plus Clarithromycin

NCT00321178 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT00321178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00321178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Trial for Early Lesions Caused by M. Ulcerans - Comparison Between 8 Weeks Streptomycin and Rifampicin (SR), or 4 Weeks SR Followed by 4 Weeks R Plus Clarithromycin
Lead sponsor
University Medical Center Groningen
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2006
Completion date
February 28, 2009
Enrollment
151 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

buruli ulcer, mycobacterium ulcerans